MLYS Competitors & Alternatives
Compare Mineralys Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MLYS
Main Stock$23.72
Tradestie Score
50
Market Cap
$3.09B
Analyst Upside
+104.5%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$9.28
|
$2.34B | - | 38 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$63.61
|
$2.33B | - | 56 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$32.48
|
$2.33B | - | 50 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$4.07
|
$2.23B | - | 33 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$27.37
|
$2.22B | - | 49 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.85
|
$2.21B | - | 61 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$20.53
|
$2.18B | - | 63 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.32
|
$2.08B | - | 63 | Compare |
More MLYS Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry